» Articles » PMID: 25634173

The Prognosis of Nasopharyngeal Carcinoma Involving Masticatory Muscles: a Retrospective Analysis for Revising T Subclassifications

Overview
Specialty General Medicine
Date 2015 Jan 31
PMID 25634173
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

This work is a retrospective study of magnetic resonance imaging (MRI) and T-stage subclassifications of nasopharyngeal carcinoma (NPC) involving the masticatory muscles (MMs). We examined how involvement of MMs influences the clinical T-stage classifications and the survival outcomes of NPC patients. MRI data as well as the medical records from 816 NPC patients were analyzed retrospectively. All cases were restaged according to the seventh edition of American Joint Committee on Cancer staging system criteria. The overall survival (OS), local relapse-free survival (LRFS), and distant metastasis-free survival (DMFS) were analyzed by the Kaplan-Meier method, and their survival outcomes between different degrees of MM involvement and different T classifications were compared by using the log-rank test. All statistical analyses were conducted on SPSS 18.0 software. P > 0.05 was considered significant. Of the 816 NPC patients analyzed, 283 (34.68%) had tumors that involved MMs. All of those 283 patients involved the medial pterygoid muscle, and 125 cases (15.32%) involved the lateral pterygoid muscle. Multivariate analysis identified MM involvement as an independent prognostic factor for patient's OS (P = 0.007) and LRFS (P = 0.024). MM involvement significantly correlated with a lower OS and LRFS (P < 0.01). In addition, compared with concurrent involvement of the medial and lateral pterygoid muscle, the medial pterygoid muscle involvement correlated with a higher OS and LRFS (P < 0.05). Among NPC patients, T-classifications 1 to 4 usually predicted the ultimate OS, LRFS, and DMFS (P > 0.1), unless the cancer involved the lateral pterygoid muscle. NPC involving the lateral pterygoid muscle presents a worse survival outcome than that involving the medial pterygoid muscle. Any cancer involving the lateral pterygoid muscle should be classified in a higher T-stage subclassification.

Citing Articles

Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification.

Pan J, Mai H, Ng W, Hu C, Li J, Chen X JAMA Oncol. 2024; .

PMID: 39388190 PMC: 11581663. DOI: 10.1001/jamaoncol.2024.4354.


Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature.

Chiang C, Guo Q, Ng W, Lin S, Ma T, Xu Z Front Oncol. 2021; 11:703995.

PMID: 34540670 PMC: 8445029. DOI: 10.3389/fonc.2021.703995.


Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.

Yang X, Wang Y, Liang S, He S, Chen D, Chen H BMC Cancer. 2018; 18(1):606.

PMID: 29843648 PMC: 5975550. DOI: 10.1186/s12885-018-4419-1.


A new T staging system for nasopharyngeal carcinoma based on intensity-modulated radiation therapy: results from a prospective multicentric clinical study.

Kang M, Zhou P, Wei T, Zhao T, Long J, Li G Am J Cancer Res. 2017; 7(2):346-356.

PMID: 28337382 PMC: 5336507.


A Study of 358 Cases of Locally Advanced Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiation Therapy: Improving the Seventh Edition of the American Joint Committee on Cancer T-Staging System.

Zhou Q, He Y, Zhao Y, Wang Y, Kuang W, Shen L Biomed Res Int. 2017; 2017:1419676.

PMID: 28265567 PMC: 5318629. DOI: 10.1155/2017/1419676.


References
1.
Lin S, Pan J, Han L, Zhang X, Liao X, Lu J . Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009; 75(4):1071-8. DOI: 10.1016/j.ijrobp.2008.12.015. View

2.
El-Sherbieny E, Rashwan H, Lubis S, Choi V . Prognostic factors in patients with nasopharyngeal carcinoma treated in Hospital Kuala Lumpur. Asian Pac J Cancer Prev. 2011; 12(7):1739-43. View

3.
Xu L, Pan J, Wu J, Pan C, Zhang Y, Lin S . Factors associated with overall survival in 1706 patients with nasopharyngeal carcinoma: significance of intensive neoadjuvant chemotherapy and radiation break. Radiother Oncol. 2010; 96(1):94-9. DOI: 10.1016/j.radonc.2010.04.006. View

4.
Galli F, Flor N, Villa C, Franceschelli G, Pompili G, Felisati G . The masticator space. Value of computed tomography and magnetic resonance imaging in localisation and characterisation of lesions. Acta Otorhinolaryngol Ital. 2010; 30(2):94-9. PMC: 2882142. View

5.
Zhao L, Zhou B, Shi M, Wang J, Xiao F, Xu M . Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China. Oral Oncol. 2012; 48(9):864-9. DOI: 10.1016/j.oraloncology.2012.03.001. View